• Most Popular
  • Most Shared

Sanofi-Aventis, Astellas to restructure Japan JV

Fri Nov 30, 2007 1:49am EST

Stocks

   

PARIS, Nov 30 (Reuters) - Sanofi-Aventis (SASY.PA) and Japanese drugmaker Astellas Pharma Inc. (4503.T) have agreed to restructure their joint venture activities in Japan, Fujisawa Sanofi-Aventis K.K. (FSA).

The operation, aimed at simplifying operational management, will be made in several steps and is expected to be substantially complete on Dec. 31, the statement said.

FSA is 51 percent owned by Sanofi-Aventis and 49 percent by Astellas. In the restructuring, Sanofi-Aventis K.K., the Japanese subsidiary of Sanofi-Aventis, will obtain certain rights to Myslee, the leading treatment of insomnia.

Myslee will continue to be co-promoted by Sanofi-Aventis K.K. and Astellas and distributed by Astellas. The other products, namely Primperan, Dogmatyl, and Gramalil will be solely marketed and distributed by Astellas. (Reporting by Dominique Vidalon, editing by Will Waterman)



More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets